Shih, Jean C.
Funding for this research was provided by:
USC Trustee Tsai Family Fund
The Boyd and Elsie Welin Professorship
Article History
Received: 23 August 2018
Accepted: 12 September 2018
First Online: 27 September 2018
Compliance with ethical standards
:
: JCS is an inventor on issued US patents 9,771,625 and 9,675,620 related to MAO inhibitor-based compounds that target prostate and brain cancers.